SAGE Therapeutics is a neuroscience-focused company developing medicines to treat life-threatening, rare CNS disorders. Our mission is to make life better for patients with central nervous systems diseases by discovering, developing, and delivering important new medicines to the market. To achieve that mission we leverage compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
SAGEÍs lead program, SAGE-547, is in clinical development for super-refractory status epilepticus (SRSE) and is the first of many compounds the company is developing in its portfolio of potential seizure medicines. SAGEÍs robust chemistry platform has generated multiple new compounds that target the GABAA and NMDA receptors, which have demonstrated preclinical activity. SAGE Therapeutics is a private company launched in 2010 by an experienced team of R&D leaders, CNS experts and investors.
- Company Name:Sage Therapeutics
(View Trends)
-
Headquarters: (View Map)Cambridge, MA, United States
-
Biotechnology
-
500 - 1,000 employees
- 1232586 Global Rank
- 237714 United States
-
Search49.25%
-
Direct32.77%
-
Referrals10.99%
-
Social6.17%
-
Mail0.82%
-
Display0.00%
- 0 SDKs
- App Url: https://itunes.apple.com/app/sage-therapeutics/id1044411289
- App Support: http://www.sagerx.com/
- Genre: Utilities
- Bundle ID: com.sage.statustrial
- App Size: 38.5 M
- Version: 1.2.0
- Release Date: October 8th, 2015
- Update Date: March 16th, 2017
Description:
The STATUS Trial App is a tool to help Study Coordinators manage some of the tasks beginning at H0/V3 in the STATUS Trial, via push notification alerts.The assessments included in the app are: PK, ECG, Vitals, Four Score, Central Labs and Daily Weight.
They are headquartered at Cambridge, MA, United States, and have 1 advertising & marketing contacts listed on Kochava. Sage Therapeutics works with Advertising technology companies such as Swoop, Google Remarketing, DoubleClick.Net, ExactTarget, Microsoft Advertising, AppNexus, Facebook Custom Audiences.
